Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sirop Sédal is a medical device developed by Laboratoires Élerté for the management of both dry and productive coughs. It functions through a mechanical mechanism of action rather than a pharmacological one, creating a protective mucoadhesive film that coats the pharyngeal mucosa. This film serves as a physical barrier, protecting the throat from contact with external irritants such as allergens, pathogens, and environmental pollutants (smoke, cold air). This barrier effect helps to soothe irritation and reduce the urge to cough. Additionally, the formulation promotes the hydration of mucus, reducing its viscosity and facilitating its physiological clearance in cases of productive cough. It is typically composed of natural ingredients including honey and botanical extracts such as marshmallow (Althaea officinalis) and plantain (Plantago lanceolata).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sirop Sédal.